Executive Summary

Medicines in Ireland must satisfy the cost-effectiveness threshold of €45,000 per QALY and a budget impact threshold of €5 million. Pharmaceutical prices in Ireland are also guided by international reference pricing, utilising a ‘reference basket‘ of 14 countries.

This page describes the product pricing policies of Ireland in detail, and explains the various stages in the process.